Kappa Index Versus Csf Oligoclonal Bands in Diagnosis of ms and Prediction of Disease Activity - Trial NCT06372977
Access comprehensive clinical trial information for NCT06372977 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Assiut University
Timeline & Enrollment
N/A
May 01, 2024
May 01, 2026
Primary Outcome
Assess the diagnostic performance of CSF k index in differentiating MS from other inflammatory and non-inflammatory neurological diseases .,Assess the diagnostic performance of CSF IgG OCBs in differentiating MS from other inflammatory and non-inflammatory neurological diseases .
Summary
To:
 
 1. Compare the diagnostic performance of cerebrospinal fluid kappa index to that of
 cerebrospinal fluid IgG oligoclonal bands in differentiating multiple sclerosis from
 other inflammatory and non-inflammatory neurological diseases .
 
 2. Assess the role of kappa free light chain and oligoclonal bands in predicting disease
 activity (conversion from clinical isolated syndrome to multiple sclerosis)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06372977
Non-Device Trial